DJIA 17,607.76 11.41 0.06%
NASDAQ 4,975.32 16.85 0.34%
S&P 500 2,061.92 4.28 0.21%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Andreas Halvorsen Increases Stake in Esperion Therapeutics

Vertex Profits Hinge on FDA Approving New Cystic Fibrosis Drug This Week

Vertex Pharma: Well Positioned To Set New Highs

Benzinga's Top #PreMarket Gainers

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog

3 Stocks Raising The Health Care Sector Higher

Pre-Clinical Data Shows Huge Potential For Resunab In Treating CF

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutic

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutics - Press Releases

Vertex Pharma Offers Data Presentations at ECFS Conference: TRAFFIC, TRANSPORT Extension Study of Lu

Vertex Pharma Offers Data Presentations at ECFS Conference: TRAFFIC, TRANSPORT Extension Study of Lumacaftor Im Combo with Ivacaftor Showed Improvements
See More Articles...